Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hendrik Schulze-Koops

Showing results (11-20 of 219) with videos related to

Pageof 22
Sort By:
Nature Reviews. Rheumatology|December 14, 2022
COVID-19 vaccination in individuals with inflammatory rheumatic diseasesAlla Skapenko, Hendrik Schulze-Koops
Rheumatology (Oxford, England)|September 15, 2017
Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithmHendrik Schulze-Koops, Alla Skapenko
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 5, 2023
Management of a patient with common variable immunodeficiency and hepatopathyLea Grümme, Hendrik Schulze-Koops
Expert Opinion on Biological Therapy|October 22, 2002
Immunosuppression with biologicals: prospects for the treatment of autoimmune diseasesHendrik Schulze-Koops, Alla Skapenko
Nature Reviews. Rheumatology|November 2, 2010
Inflammation: TREG cell control of autoimmune inflammation: a matter of timing?Hendrik Schulze-Koops, Alla Skapenko
Zeitschrift Fur Rheumatologie|January 6, 2023
[Rheumatological side effects of checkpoint inhibitors and their treatment]Lea Grümme, Hendrik Schulze-Koops
Nature Reviews. Rheumatology|November 22, 2017
Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatmentJoachim R Kalden, Hendrik Schulze-Koops
Arthritis Research|July 11, 2002
22nd European Workshop for Rheumatology Research, Leiden, The Netherlands, 28 February-3 March 2002Andrew P Cope, Hendrik Schulze-Koops
Pediatric Rheumatology Online Journal|July 6, 2011
1.5 Decades Later: Bearing fruits from the ACR/EULAR exchange ProgramRandy Q Cron, Hendrik Schulze-Koops
Nature Reviews. Rheumatology|July 29, 2009
Prognostic factors in rheumatoid arthritis in the era of biologic agentsAlla Skapenko, Iryna Prots, Hendrik Schulze-Koops
Pageof 22

Showing results (11-20 of 219) with videos related to

Sort By:
Pageof 22
Nature Reviews. Rheumatology|December 14, 2022
COVID-19 vaccination in individuals with inflammatory rheumatic diseasesAlla Skapenko, Hendrik Schulze-Koops
Rheumatology (Oxford, England)|September 15, 2017
Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithmHendrik Schulze-Koops, Alla Skapenko
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 5, 2023
Management of a patient with common variable immunodeficiency and hepatopathyLea Grümme, Hendrik Schulze-Koops
Expert Opinion on Biological Therapy|October 22, 2002
Immunosuppression with biologicals: prospects for the treatment of autoimmune diseasesHendrik Schulze-Koops, Alla Skapenko
Nature Reviews. Rheumatology|November 2, 2010
Inflammation: TREG cell control of autoimmune inflammation: a matter of timing?Hendrik Schulze-Koops, Alla Skapenko
Zeitschrift Fur Rheumatologie|January 6, 2023
[Rheumatological side effects of checkpoint inhibitors and their treatment]Lea Grümme, Hendrik Schulze-Koops
Nature Reviews. Rheumatology|November 22, 2017
Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatmentJoachim R Kalden, Hendrik Schulze-Koops
Arthritis Research|July 11, 2002
22nd European Workshop for Rheumatology Research, Leiden, The Netherlands, 28 February-3 March 2002Andrew P Cope, Hendrik Schulze-Koops
Pediatric Rheumatology Online Journal|July 6, 2011
1.5 Decades Later: Bearing fruits from the ACR/EULAR exchange ProgramRandy Q Cron, Hendrik Schulze-Koops
Nature Reviews. Rheumatology|July 29, 2009
Prognostic factors in rheumatoid arthritis in the era of biologic agentsAlla Skapenko, Iryna Prots, Hendrik Schulze-Koops
Pageof 22